Navigating approval pathways for immunotherapy in NSCLC: should criteria be revised?
Nat Rev Clin Oncol
; 20(7): 423-424, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37041274
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Limits:
Humans
Language:
En
Journal:
Nat Rev Clin Oncol
Journal subject:
NEOPLASIAS
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom